These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28760610)

  • 1. Macrophage-derived insulin-like growth factor-1 affects influenza vaccine efficacy through the regulation of immune cell homeostasis.
    Yoon IS; Park H; Kwak HW; Woo Jung Y; Nam JH
    Vaccine; 2017 Aug; 35(36):4687-4694. PubMed ID: 28760610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD47 Plays a Role as a Negative Regulator in Inducing Protective Immune Responses to Vaccination against Influenza Virus.
    Lee YT; Ko EJ; Lee Y; Lee YN; Bian Z; Liu Y; Kang SM
    J Virol; 2016 Aug; 90(15):6746-6758. PubMed ID: 27194758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
    Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A
    Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivated influenza vaccine adjuvanted with bacterium-like particles induce systemic and mucosal influenza A virus specific T-cell and B-cell responses after nasal administration in a TLR2 dependent fashion.
    Keijzer C; Haijema BJ; Meijerhof T; Voorn P; de Haan A; Leenhouts K; van Roosmalen ML; van Eden W; Broere F
    Vaccine; 2014 May; 32(24):2904-10. PubMed ID: 24598720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.
    Trondsen M; Aqrawi LA; Zhou F; Pedersen G; Trieu MC; Zhou P; Cox RJ
    Scand J Immunol; 2015 May; 81(5):305-17. PubMed ID: 25737202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse strain and sex as determinants of immune response to trivalent influenza vaccine.
    Petrović R; Bufan B; Arsenović-Ranin N; Živković I; Minić R; Radojević K; Leposavić G
    Life Sci; 2018 Aug; 207():117-126. PubMed ID: 29859986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crucial roles of interleukin-7 in the development of T follicular helper cells and in the induction of humoral immunity.
    Seo YB; Im SJ; Namkoong H; Kim SW; Choi YW; Kang MC; Lim HS; Jin HT; Yang SH; Cho ML; Kim YM; Lee SW; Choi YK; Surh CD; Sung YC
    J Virol; 2014 Aug; 88(16):8998-9009. PubMed ID: 24899182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine-specific antibody secreting cells are a robust early marker of LAIV-induced B-cell response in ferrets.
    Cherukuri A; Servat E; Woo J
    Vaccine; 2012 Jan; 30(2):237-46. PubMed ID: 22080173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective neutralizing influenza antibody response in the absence of T follicular helper cells.
    Miyauchi K; Sugimoto-Ishige A; Harada Y; Adachi Y; Usami Y; Kaji T; Inoue K; Hasegawa H; Watanabe T; Hijikata A; Fukuyama S; Maemura T; Okada-Hatakeyama M; Ohara O; Kawaoka Y; Takahashi Y; Takemori T; Kubo M
    Nat Immunol; 2016 Dec; 17(12):1447-1458. PubMed ID: 27798619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.
    Bungener L; Geeraedts F; Ter Veer W; Medema J; Wilschut J; Huckriede A
    Vaccine; 2008 May; 26(19):2350-9. PubMed ID: 18400340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of apoptosis-associated speck-like protein containing a caspase recruitment domain on vaccine efficacy: Overcoming the effects of its deficiency with aluminum hydroxide adjuvant.
    Lee DK; Lee EY; Kim RH; Kwak HW; Kim JY; Kim H; Kang KW; Lee SM; Park JH; Chang J; Nam JH
    Microbiol Immunol; 2018 Mar; 62(3):176-186. PubMed ID: 29315762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced immune responses by skin vaccination with influenza subunit vaccine in young hosts.
    Koutsonanos DG; Esser ES; McMaster SR; Kalluri P; Lee JW; Prausnitz MR; Skountzou I; Denning TL; Kohlmeier JE; Compans RW
    Vaccine; 2015 Sep; 33(37):4675-82. PubMed ID: 25744228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
    Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strain specificities in influence of ageing on germinal centre reaction to inactivated influenza virus antigens in mice: Sex-based differences.
    Bufan B; Arsenović-Ranin N; Petrović R; Živković I; Stoiljković V; Leposavić G
    Exp Gerontol; 2020 May; 133():110857. PubMed ID: 32006634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses.
    Gallorini S; Taccone M; Bonci A; Nardelli F; Casini D; Bonificio A; Kommareddy S; Bertholet S; O'Hagan DT; Baudner BC
    Vaccine; 2014 Apr; 32(20):2382-8. PubMed ID: 24434044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design.
    Bessa J; Schmitz N; Hinton HJ; Schwarz K; Jegerlehner A; Bachmann MF
    Eur J Immunol; 2008 Jan; 38(1):114-26. PubMed ID: 18081037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung.
    Neuhaus V; Chichester JA; Ebensen T; Schwarz K; Hartman CE; Shoji Y; Guzmán CA; Yusibov V; Sewald K; Braun A
    Vaccine; 2014 May; 32(26):3216-22. PubMed ID: 24731807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza.
    Huber VC; McKeon RM; Brackin MN; Miller LA; Keating R; Brown SA; Makarova N; Perez DR; Macdonald GH; McCullers JA
    Clin Vaccine Immunol; 2006 Sep; 13(9):981-90. PubMed ID: 16960108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
    Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J
    J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.